|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the US Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health.
|
|
Analytical Methods and Reference Materials Program
|
Resource Development
|
Not Reported
|
OD/DPCPSI/ODS
|
The National Institutes of Health's, Office of Dietary Supplement Analytical Methods and Reference Materials Program (AMRM) collaborates with NIH ICOs and other federal agencies to support the development and dissemination of research resources that scientists and analysts need to ensure that chemical characterizations of dietary supplements, natural products, and nutrient biomarkers are accurate, precise, reliable, and reproducible.
|
|
Annexes to the Playbook on Biological Incident Preparedness and Response - Clinical Research Response and Response Research Agenda
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
Will define the process by which the United States will implement clinical trials of vaccines, diagnostics, or medical countermeasures in affected foreign countries even when there is no pre-existing research platform. To rapidly assess what knowledge gaps exist around a particular pathogen, its transmission, ecology, or management, in order to create a prioritized research agenda to guide medium and long-term research activities
|
|
Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ, CDC
|
FIC, NCI, NHGRI, NHLBI, NIAAA, NIDA, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD/DPCPSI/ODP
|
Annual Conference on the Science of Dissemination and Implementation is a forum for discussing the science of dissemination and implementation and aims to grow the research base by bridging the gap between evidence, practice, and policy in health and medicine. Researchers, evaluators, and implementers who are interested in identifying opportunities, challenges, and strategies for disseminating the findings and implementation of research to key stakeholders are encouraged to attend. Discuss, debate, and explore in-depth approaches to advance dissemination and implementation science.
|
|
Antibody Interest Group (ABIG)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, NHLBI, NIAID, NIDCR, NIDDK
|
The NIH ABIG promotes information exchange and interaction among NIH scientists who work on various aspects of antibody engineering and therapy. The success of antibody therapy requires a thorough understanding of biological systems in relation to molecular and cell biology, immunology, biochemistry, and microbiology, as well as diseases such as cancer, autoimmunity, and infectious diseases. Interest in antibody therapy crosses traditional biomedical disciplinary boundaries. ABIG provides an open forum for multidisciplinary discussion among colleagues who otherwise may have limited interaction. The principal ABIG activities are monthly meetings on current topics as well as an annual symposium on the NIH campus. The monthly ABIG meetings are open to everyone interested. These meetings are devoted to research seminars on numerous aspects of antibody engineering and therapy presented by both NIH scientists and outside speakers.
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC
|
NICHD
|
This is a registry of use of antiretroviral drugs in pregnancy that is sponsored by various pharmaceutical companies and has a committee of external experts and government staff from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). The registry provides a resource for clinicians and researchers to improve the healthcare quality and patient safety for HIV infected mothers and their infants. http://www.apregistry.com/
|
|
AoURP and Veterans Administration
|
Other
|
AoA
|
OD/All of Us
|
Enrollment award to support engagement, enrollment and retention across 17 cities for VA clinic locations to facilitate participation in AOURP among the veteran population.Collaboration Type: award to the VA for enrollment and retention of AOU participants
|
|
ARPA-H Biomedical Data Fabric Toolbox program partnership
|
Resource Development
|
Not Reported
|
ARPA-H, NCATS, NCI, NHGRI, NHLBI, NIAID, NIBIB, NIEHS, OD/DPCPSI
|
To support both the mission of ARPA-H to “Accelerate better health outcomes for everyone by supporting the development of high-impact solutions to society's most challenging health problems,” and the NCI’s vision to “Maximize cancer data availability, usability, and utility through forward-thinking policies and processes”, NCI and ARPA-H are partnering to advance Biomedical Data Fabric research efforts for cancer and integrate advanced capabilities from across DARPA and NIH Institutes and Centers.
|
|
ASPR Respiratory Protective Device (RPD) Working Group and ASPR Gowns/Gloves Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
ASPR
|
OD/OM, OD/OM/ORS
|
These working groups will perform a validation process of existing and new PPE requirements in support of the upcoming MCM Preparedness Review due to Congress in 2023. This Review includes efforts historically referred to as the Strategic National Stockpile (SNS) Annual Review.
|
|
Assessing the Burden of Diabetes by Type in Children, Adolescents, and Young Adults Network
|
Resource Development
|
CDC
|
NIDDK
|
The primary goal of the DiCAYA network is to modernize diabetes surveillance efforts to capitalize on large-volume, electronic health record data streams and on recent advances in statistics and clinical informatics to provide accurate, timely, cost-effective, granular, and representative indicators of diabetes prevalence and incidence among children, adolescents and younger adults. The network aims to monitor overall trends as well as trends within subgroups (e.g., age, sex, diabetes type, socioeconomic status, urbanicity, geographic area). NIDDK is a DiCAYA research sponsor.
|